How Has the Prescription Dermatological Drugs Market Size Evolved in Recent Years?
The prescription dermatological drugs market has seen considerable growth due to a variety of factors.
• The market size for prescription dermatological medicines has seen substantial growth recently. It is expected to escalate from $37.77 billion in 2024 to $40.38 billion in 2025, with a compound annual growth rate (CAGR) of 6.9%.
Factors contributing to this growth during the historic period include a higher incidence of skin disorders, increasing awareness about skin health, the enhancement of dermatology clinics, an aging population, higher healthcare expenditure, and an increase in research and development investments.
What Are The Predictions for The Prescription Dermatological Drugs Market in the Coming Years?
The prescription dermatological drugs market is expected to maintain its strong growth trajectory in upcoming years.
• The market for prescription dermatological drugs is predicted to witness significant expansion in the ensuing years, reaching $52.27 billion in 2029 with an annual growth rate of 6.7%.
This upsurge during the forecast period is due to factors like increasing instances of skin disorders, heightened awareness about skin health, wider adoption of telemedicine for dermatology consultations, the boom in the skincare aesthetics field, wider insurance coverage for dermatological procedures, and an uptick in demand for personalized and precision dermatology. We can expect several emerging trends in this forecast period such as the creation of targeted biological therapies, the use of gene editing for treating skin conditions, advancements in drug delivery mechanisms, the application of personalized treatments via genetic profiling, the use of topical medications with better absorption, along with the utilization of artificial intelligence to fine-tune drug mixes and treatment programs.
Which Drivers Are Accelerating Growth In The Prescription Dermatological Drugs Market?
The forecasted expansion of the prescription dermatological drugs market is largely influenced by the rising occurrence of skin, hair and nail disorders, including eczema, psoriasis and acne. The escalating incidence of such dermatological issues is primarily attributed to increased exposure to environmental pollutants, changes in lifestyle, and heightened stress levels. Prescription dermatological medications are vital for effectively managing these conditions, providing specific treatments to soothe symptoms and enhance skin health in the long run. For example, as reported by Europe PubMed Central, a UK-based organization situated at EMBL’s European Bioinformatics Institute, a research study was conducted across 27 European countries in March 2022. According to their findings, around 43.35% of the participants, corresponding to roughly 185 million people, suffered from a minimum of one skin disorder. The most recurrent conditions were fungal infections, atopic dermatitis, and acne. Consequently, the rising frequency of dermatological diseases is propelling the growth of the prescription dermatological drugs market.
What Are The Core Segments Of The Global Prescription Dermatological Drugs Market?
The prescription dermatological drugs market covered in this report is segmented –
1) By Drug Class: Corticosteroids, Retinoids, Calcineurin Inhibitors, Antifungal Agents, Antibiotics, Other Drug Classes
2) By Indication: Acne, Psoriasis, Dermatitis, Fungal Skin Infections, Other Indications
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels
Subsegments:
1) By Corticosteroids: Topical Corticosteroids, Oral Corticosteroids, Injectable Corticosteroids
2) By Retinoids: Topical Retinoids, Oral Retinoids
3) By Calcineurin Inhibitors: Topical Calcineurin Inhibitors, Oral Calcineurin Inhibitors
4) By Antifungal Agents: Topical Antifungals, Oral Antifungals
5) By Antibiotics: Topical Antibiotics, Oral Antibiotics
6) By Other Drug Classes: Immunosuppressants, Phototherapy Agents
Pre-Book The Prescription Dermatological Drugs Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What New Trends Are Influencing The Prescription Dermatological Drugs Market?
Leading firms in the prescription dermatological medications market are concentrating their efforts on the creation of innovative treatments such as prurigo nodularis. These initiatives are geared towards addressing unfulfilled medical needs and providing more effective remedies for patients affected by persistent and serious skin illnesses. Prurigo nodularis is described as a long-standing skin disease marked by extremely itchy, elevated, hardened nodules on skin. For example, Regeneron Pharmaceuticals Inc, a US biotech firm, in collaboration with Sanofi S.A, a French pharmaceutical company, received approval for Dupixent (dupilumab) from FDA in September 2022. This became the inaugural FDA authorized treatment for Prurigo Nodularis, a chronic skin disease known for its intensely itchy nodules. The approval came following clinical trials that indicated notable improvements in the severity of the itch and skin lesions in patients administered with Dupixent, compared to those given placebos.
Who Are the Key Players In The Prescription Dermatological Drugs Market?
Major companies operating in the prescription dermatological drugs market are:
• Pfizer Inc.
• Johnson & Johnson
• Merck KGaA
• AbbVie Inc.
• Bayer AG
• Novartis AG
• GSK plc
• Amgen Inc.
• Teva Pharmaceutical Industries Ltd.
• Intas Pharmaceuticals Inc.
• Regeneron Pharmaceuticals Inc.
• Mylan NV
• Sun Pharmaceutical Industries Ltd.
• Cipla Limited
• Dr. Reddy's Laboratories Ltd.
• Zydus Cadila Health Care Limited
• Leo Pharma A/S
• Glenmark Pharmaceuticals Limited
• Almirall S.A.
• DermBiont Inc.
What Are The Regional Insights Into The Prescription Dermatological Drugs Market?
North America was the largest region in the prescription dermatological drugs market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the prescription dermatological drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
